CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 2 Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravenous USB002 to Treat Patients With Respiratory Distress Due to COVID-19 Infection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04778059
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:26.279750+00:00
Published At: 2023-12-01T00:00:00+00:00
Record Updated At: 2023-12-01
Results Posted At: 2023-12-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["2019 Novel Coronavirus Infection", "COVID-19 Virus Infection", "SARS Coronavirus 2 Infection", "SARS-CoV-2 Infection", "Respiratory Distress Syndrome, Adult", "Adult Respiratory Distress Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-12-01"
protocolSection.identificationModule.nctId: "NCT04778059"
protocolSection.identificationModule.officialTitle: "Phase 2 Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravenous USB002 to Treat Patients With Respiratory Distress Due to COVID-19 Infection"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-12-01"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.